Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma (Q33364244)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q46643038)
(Q60683880)
(Q104437536)
(P304) 676-684
(P407) (Q1860)
(P433) 4
(P478) 23
(P577) Tuesday, December 21, 2004
(P921) (Q181600)
(Q268713)
(P1433) (Q400292)
(P1476) "Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma" (language: en)
(P2093) John Wright
Craig Moskowitz
Jamie Muzzy
Barbara MacGregor-Cortelli
Michael Stubblefield
David Straus
Carol Portlock
Elizabeth Choi
Otila Dumetrescu
Dixie Esseltine
Elizabeth Trehu
Julian Adams
David Schenkein
(P2860) (Q27860529)
other details
description scientific article

External Links